GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 276 - 300 of 4050 in total
Antibody Patient Onset (days) Symptom ▲ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 2 15 mild
G00057MO
115
IgG Patient 2 15 mild
G00065MO
57
IgG Patient 2 15 mild
G00066MO
185
IgG Patient 2 15 mild
G00068MO
31
IgG Patient 2 15 mild
G02557XE
26
IgG Patient 2 15 mild
G02670IJ
32
IgG Patient 2 15 mild
G03499BP
45
IgG Patient 2 15 mild
G07483YN
31
IgG Patient 2 15 mild
G08340FW
6474
IgG Patient 2 15 mild
G08520NM
36
IgG Patient 2 15 mild
G09482NW
49
IgG Patient 2 15 mild
G09609EN
91
IgG Patient 2 15 mild
G10133VD
82
IgG Patient 2 15 mild
G10789DJ
531
IgG Patient 2 15 mild
G11460AB
74
IgG Patient 2 15 mild
G12200GB
297
IgG Patient 2 15 mild
G14569AR
9879
IgG Patient 2 15 mild
G14844CX
31
IgG Patient 2 15 mild
G14988WV
162
IgG Patient 2 15 mild
G15209MJ
459
IgG Patient 2 15 mild
G15407YE
3047
IgG Patient 2 15 mild
G16579HJ
47
IgG Patient 2 15 mild
G17140UR
91
IgG Patient 2 15 mild
G17266GE
41
IgG Patient 2 15 mild
G17390SF
34

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024